Mycoplasma genitalium

From IDWiki
Mycoplasma genitalium /
Revision as of 16:10, 10 April 2024 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Clinical Manifestations

Differential Diagnosis

Management

Canadian Guidelines

  • Suspected cervicitis or urethritis:
    • Not previously treated with azithromycin: Azithromycin 500 mg PO on day one followed by 250 mg PO daily for days two to five
    • Previously treated with azithromycin: moxifloxacin 400 mg PO daily for 7 days
  • Suspected or confirmed macrolide-resistance: moxifloxacin 400 mg PO daily for 7 days
  • Suspected or confirmed pelvic inflammatory disease: moxifloxacin 400 mg PO daily for 14 days, in addition to standard treatment for PID
  • Unclear if test-of-cure is required; if done, wait at least 3 weeks before sending NAAT

American Guidelines (2021)

  • Macrolide-susceptible: doxycycline 100 mg p.o. twice daily for 7 days followed by azithromycin 1 g p.o. once followed by 500 mg po.o. daily for 3 more days
  • Macrolide-resistant, or testing unavailable: doxycycline 100 mg p.o. twice daily for 7 days followed by moxifloxacin 400 mg p.o. daily for 7 days
  • Test-of-cure not recommended for asymptomatic people
  • If symptoms are persistent, treat with moxifloxacin

European Guidelines (2016)

  • Macrolide-susceptible: azithromycin 500 mg p.o. on day one, followed by 250 mg daily on days 2 to 5
  • Macrolide-resistant, or second-line: moxifloxacin 400 mg p.o. daily for 7 to 10 days
  • Third-line:
    • Doxycycline 100 mg p.o. twice daily for 14 days (eradication in about 30%)
    • Pristinamycin 1 g p.o. four times daily for 10 days
  • Complicated infection involving PID or epididymitis: moxifloxacin 400 mg p.o. daily for 14 days
  • Test-of-cure is recommended as routine, collected at least 3 weeks after start of treatment

Further Reading